Seeing Is Believing
with an average price target of $18.7. This is a potential upside of $8.14 (77.08%) from yesterday's end of day stock price of $10.56.
Audentes Therapeutics's activity chart (see below) currently has 27 price targets and 18 ratings on display.
Analysts average stock forecasts to be materialized ratio is 97.22% with an average time for these price targets to be met of 208 days.
Most recent stock forecast was given by JOSEPH SCHWARTZ from LEERINK on 04-Dec-2019. First documented stock forecast 01-May-2017.
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
48
4 years 4 months 16 days ago
4/4 (100%)
$9.47 (24.58%)
224
Hold
45
4 years 4 months 17 days ago
4/4 (100%)
$8.67 (23.86%)
290
Buy
55
4 years 4 months 17 days ago
9/9 (100%)
$26.55 (93.32%)
264
Hold
48
4 years 4 months 17 days ago
7/7 (100%)
$7.87 (19.61%)
90
Hold
57
4 years 4 months 17 days ago
2/2 (100%)
$17.02 (43.32%)
468
What is BOLD (Audentes Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on BOLD (Audentes Therapeutics) with a proven track record?
Which analyst has the current lower performing score on BOLD (Audentes Therapeutics) with a proven track record?
Which analyst has the most public recommendations on BOLD (Audentes Therapeutics)?
Which analyst is the currently most bullish on BOLD (Audentes Therapeutics)?
Which analyst is the currently most reserved on BOLD (Audentes Therapeutics)?